Spots Global Cancer Trial Database for dabrafenib and trametinib combination therapy
Every month we try and update this database with for dabrafenib and trametinib combination therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD). | NCT01682083 | Melanoma | Dabrafenib Trametinib Placebos | 18 Years - | Novartis | |
Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD). | NCT01682083 | Melanoma | Dabrafenib Trametinib Placebos | 18 Years - | Novartis |